Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RIC3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | KCNB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | HPCA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | ZNF738 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | CHCHD4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | KMT2E | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | COPS2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | HARS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | NFAT5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | MEX3C | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |